|
Thymectomy Trial In Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy (MGTX)
| Principal Investigator |
Gary Cutter, PhD, Gil Wolfe, MD |
| Site-PI |
Michael Benatar, MD, PhD |
| Summary |
The purpose of this multi-center, randomized controlled trial is to determine if extended trans-sternal thymectomy combined with prednisone therapy is more beneficial in treating patients with non-thymomatous myasthenia gravis than prednisone alone. |
| Eligibility criteria |
- Generalized myasthenia gravis, onset within last 5 years
- Positive acetylcholine receptor binding antibodies
- Age 18-65
- MGFA class II-IV
- No immunosuppressive therapy other than prednisone for one year
- No thymoma
|
| Funding agency |
National Institutes of Health |
| Collaborators |
Gil Wolfe, MD
Gary Cutter, PhD
Henry Kaminski, MD |
| Project manager |
Alexandra Waltz, MA
Email:
Phone: 305-243-3799
|
| Contact information |
|
| Links |
http://www.soph.uab.edu/mgtx/index.htm |
| Presentations / Publications |
|
|
